Regal Healthcare Capital Partners Closes Oversubscribed Third Fund at $415 Million

Regal Healthcare Capital Partners (“Regal”), a private equity firm based in New York City, has announced the successful closing of its third fund, RHCP III, L.P. (“Fund III”). The fund reached its hard cap of $415 million, including commitments from the general partner. This achievement underscores Regal’s strong position in the healthcare investment sector and the confidence investors have in their focused strategy.

Raised in under a month, Fund III significantly exceeded its initial target of $325 million, demonstrating substantial investor demand. Regal Healthcare Capital Partners will continue its proven approach of partnering with leading entrepreneurs within the healthcare services industry. This new fund, combined with Regal’s previous two funds raised in 2018 and 2019, brings the firm’s total managed capital to over $665 million, solidifying its position as a significant player in healthcare private equity.

A notable aspect of this fundraise is the continued support from Regal’s existing investor base. Approximately $350 million of Fund III’s commitments came from investors in prior Regal Healthcare Capital Partners funds, indicating strong satisfaction and trust in the firm’s performance. In addition to returning investors, Regal also attracted interest from new high-quality institutions, selectively inviting a group to participate in Fund III. Furthermore, Regal’s general partners have committed over $100 million to invest alongside Fund III, aligning their interests with those of their limited partners.

David Kim, MD, General Partner at Regal Healthcare Capital Partners, expressed gratitude for the strong support from both existing and new limited partners. He emphasized the firm’s commitment to partnering with leading entrepreneurs to develop successful healthcare businesses. Jon Santemma, General Partner at Regal, added his enthusiasm for building upon the success of their first two funds and delivering excellent returns to their investors through Fund III.

DLA Piper provided legal counsel to Regal Healthcare Capital Partners for this fund closing. Regal did not utilize a placement agent for the fundraising.

About Regal Healthcare Capital Partners

Regal Healthcare Capital Partners is a New York-based private equity firm exclusively focused on investments in lower-middle market healthcare services companies. Regal aims to collaborate with healthcare entrepreneurs across the United States, focusing on enhancing the quality, accessibility, and convenience of patient care. The firm typically targets equity investments ranging from $20 to $70 million per opportunity, in companies with revenues between $20 and $100 million. For further details, please visit www.regalhcp.com.

Contact:
Regal Investor Relations
212-393-4790
[email protected]

Source: Regal Healthcare Capital Partners

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *